Naoto Hirano
Department of Medical Oncology
Dana-Farber Cancer Institute
44 Binney St
Boston
USA
Name/email consistency: high
- Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia. Hirano, N., Butler, M.O., Xia, Z., Berezovskaya, A., Murray, A.P., Ansén, S., Kojima, S., Nadler, L.M. Blood (2006)
- Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Hirano, N., Butler, M.O., Xia, Z., Ansén, S., von Bergwelt-Baildon, M.S., Neuberg, D., Freeman, G.J., Nadler, L.M. Blood (2006)
- Efficient presentation of naturally processed HLA class I peptides by artificial antigen-presenting cells for the generation of effective antitumor responses. Hirano, N., Butler, M.O., Xia, Z., Berezovskaya, A., Murray, A.P., Ansén, S., Nadler, L.M. Clin. Cancer Res. (2006)
- Presence of anti-kinectin and anti-PMS1 antibodies in Japanese aplastic anaemia patients. Hirano, N., Butler, M.O., Guinan, E.C., Nadler, L.M., Kojima, S. Br. J. Haematol. (2005)
- Autoantibodies frequently detected in patients with aplastic anemia. Hirano, N., Butler, M.O., Von Bergwelt-Baildon, M.S., Maecker, B., Schultze, J.L., O'Connor, K.C., Schur, P.H., Kojima, S., Guinan, E.C., Nadler, L.M. Blood (2003)
